Tamiflu

(redirected from Oseltamivir phosphate)
Also found in: Medical.

Tam·i·flu

 (tăm′ə-flo͞o′)
A trademark for the phosphate form of the drug oseltamivir.

Tamiflu

(ˈtæmɪˌfluː)
n
(Pathology) trademark an oral antiviral drug that attacks the influenza virus and prevents it spreading inside the body
References in periodicals archive ?
Amneal Pharmaceuticals has launched oseltamivir phosphate for oral suspension, the company's AB-rated therapeutic equivalent for Tamiflu, in a 6 mg/mL strength.
The Food and Drug Administration has approved the first generic version of Tamiflu (oseltamivir phosphate), a medication for the treatment of influenza A and B.
(17.) Roche Laboratories Tamiflu (oseltamivir phosphate) Capsule and for oral suspension 2008 Retrieved from: http://www.fda.gov/downloads/ Drugs/DrugSafety/InformationbyDrugClass/UCM 147992.pdf
According to the company, Influenza A H1N1 infected animals treated with FluCide survived the full 21-day observation period, whereas animals treated with 40mg/kg/d oseltamivir phosphate (Tamiflu) survived only eight days in this highly lethal study.
Food and Drug Administration (FDA) approved oseltamivir phosphate (Tamiflu[R]) for treatment in children as young as two weeks old (FDA, 2012).
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.
Tamiflu is the brand name for oseltamivir phosphate. "Something happened in 2008, when drug resistance took hold," notes Daniel Janies, primary author of the study.
Tamiflu is the trade name for oseltamivir phosphate.
Of the total 40 million doses of Tamiflu, or Oseltamivir phosphate, 20 million doses have already been used up.
Oseltamivir phosphate, marketed as Tamiflu, is a popular neuraminidase inhibitor widely used to treat flu symptoms.